HCA2 is the most well developed, with its naturally occurring ligand, niacin, having been widely used clinically to control dyslipidaemia through a mechanism that is at least partly mediated by HCA2 (102). The gene discussed is HCAR2; the disease is inherited lipid metabolism disorder.